Publisher's Synopsis
GUIDELINES Pocketcard is a tri-fold pocketcard containing society-endorsed, evidence-based treatment guidelines in a brief algorithmic format that is most preferred by practicing clinicians, quality managers, nurses, educators, and medical students.1, 2 The Bone-Modifying Agents in Metastatic Breast Cancer GUIDELINES Pocketcard is endorsed by the American Society of Clinical Oncology (ASCO) and based on their latest guidelines. This practical quick-reference tool includes timing of therapy, a management algorithm, FDA-approved drug list, toxicities and safety concerns-all the essential components from ASCO's full-text guidelines-and is approved by the ASCO Practice Guidelines Committee. The Bone-Modifying Agents in Metastatic Breast Cancer GUIDELINES Pocketcard provides all that is needed to make accurate clinical decisions at the point of care including: Key Points; Indications and Timing of Therapy; Role of BMAs in the Presence of Extraskeletal Metastases; Laboratory Monitoring; Drug Toxicities and Risks; Osteonecrosis of the Jaw; Role of BMAs in Pain Control; Management Algorithm; Current Medication Tables with Brand and Generic Names. Applications: point-of-care, education, QI interventions, clinical trials, medical reference, clinical research. 12007 PDR Physician Survey. 2VA-HHS national guidelines attribute preference survey.
